Nialll Cairns
Get their honest, personalized take on your startup.
Sign in to pitch Nialll →At a glance
- Full Name
- Niall Charles Edgar Cairns
- Title
- Managing Director & Co-Founder
- Firm
- Kestrel Capital Pty Ltd
- Firm Type
- Venture Capital / Private Equity (early-stage & growth technology investor)
- Investment Stage
- Seed, Venture Capital, and Growth / Private Equity
- Target Company Profile
- Growth companies with global opportunities, typically technology-driven, spanning both unlisted and listed developing companies
- Sector Focus
- Technology growth companies — digital media, agtech, medtech, consumer internet, SaaS, resources, niche manufacturing and services
- Geographic Focus
- Australia and New Zealand primarily, with cross-border activity in the US, UK, and China
- Location
- Sydney, NSW, Australia (Suite 301, 55 Lime Street)
Background
Niall Cairns is a Sydney-based technology investor with over 25 years of direct seed, venture capital, private equity, and listed-company experience focused on technology growth companies. He holds a Bachelor of Economics (studying economics, accountancy, and law) from the University of Sydney (1981–1984) and is a Chartered Accountant (CA / ACA). He co-founded Nanyang Ventures in 1993, serving as Managing Director, and led its transformation into Kestrel Capital, where he continues as Managing Director and Co-Founder.
Across his career, Cairns has invested in more than 30 unlisted companies — and many more listed developing companies — and has been credited with helping drive the global growth of over 50 companies. At Kestrel/Nanyang he raised six funds (including three licensed by Innovation Australia) and served as a director of numerous portfolio businesses, delivering a track record of value creation, restructuring, and exits across both listed and unlisted companies.
Beyond his fund work, Cairns is Executive Chairman and Co-Founder of CardieX Limited (ASX: CDX), a health-technology company built around the AtCor Medical arterial-health business, and has held executive/chairman roles connected to CONNEQT Health, Tambla Limited, and Tru-Test. He currently sits on the Investment Committees of Kestrel Structured Capital, Kestrel Growth Companies, and the KTT (Kestrel) fund. His broader board and community roles have included Non-Executive Chairman of the St Andrew's College Foundation, and membership of the Young Presidents' Organization (Sydney).
Investment Thesis & Focus
- Invests across the full lifecycle — from seed and venture capital through growth-stage private equity — in technology companies with global expansion potential.
- Backs "growth companies with global opportunities" concentrated in technology, resources, niche manufacturing and services, with a modern sector emphasis on digital media, agtech, medtech, consumer internet and SaaS.
- Emphasizes value creation, restructuring, and exits — a hands-on, director-level operating approach rather than passive capital.
- Comfortable with both listed and unlisted companies and cross-border deals (Australia, NZ, US, UK, China).
Notable Investments
- CardieX Limited (ASX: CDX) / AtCor Medical — arterial-health medtech company; Cairns is Executive Chairman and Co-Founder.
- Avand — enterprise software business; sold to TechnologyOne (ASX: TNE).
- Intrapower — telecom/IT company; sold to TPG Telecom.
- GMD — technology/services company; sold to SMS Management & Technology.
- Gale Pacific — manufacturing/materials company; AVCAL award-winning investment.
- Australian Helicopters — aviation services company; Kestrel/Nanyang portfolio investment and directorship.
- Tru-Test Corporation — New Zealand agtech/measurement group; served as Non-Executive Director.
- Tambla Limited — Australian workforce-management software company (board/executive involvement).
Unlock the full research
Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.
One-time. Stays unlocked for you.